ALGN - Align Technology, Inc
188.29
| Index: | S&P 500 | P/E: | 34.26 | EPS (ttm): | 5.50 | Insider Own: | 6.34% | Shs Outstand: | 73.06M | Perf Week: | 3.52% |
| Market Cap: | 13.65B | Forward P/E: | 16.73 | EPS next Y: | 11.25 | Insider Trans: | 0.00% | Shs Float: | 67.89M | Perf Month: | 12.63% |
| Income(ttm): | 409.56M | PEG: | 3.42 | EPS next Q: | 2.57 | Inst Own: | 93.55% | Short Float: | 4.71% | Perf Quarter: | -8.94% |
| Revenue(ttm): | 3.98B | P/S: | 3.43 | EPS this Y: | 10.25% | Inst Trans: | 2.02% | Short Ratio: | 2.47 | Perf Half Y: | -14.06% |
| Book/sh: | 51.94 | P/B: | 3.63 | EPS next Y: | 9.41% | ROA: | 6.68% | Short Interest: | 3.19M | Perf Year: | -32.29% |
| Cash/sh: | 12.04 | P/C: | 15.63 | EPS next 5Y: | 10.02% | ROE: | 10.84% | 52W Range: | 141.74 - 283.00 | Perf YTD: | -9.70% |
| Dividend Est.: | - | P/FCF: | 21.64 | EPS past 5Y: | 0.33% | ROI: | 10.55% | 52W High: | -33.47% | Beta: | 1.66 |
| Dividend TTM: | - | Quick Ratio: | 1.08 | Sales past 5Y: | 12.81% | Gross Margin: | 70.40% | 52W Low: | 32.84% | ATR (14): | 7.49 |
| Dividend Ex-Date: | - | Current Ratio: | 1.21 | EPS Y/Y TTM: | -9.60% | Oper. Margin: | 16.40% | RSI (14): | 61.52 | Volatility: | 2.85% 3.75% |
| Employees: | 20945 | Debt/Eq: | 0.03 | Sales Y/Y TTM: | 1.64% | Profit Margin: | 10.29% | Recom: | 1.95 | Target Price: | 232.23 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.02 | EPS Q/Q: | -9.18% | Payout: | 0.00% | Rel Volume: | 0.54 | Prev Close: | 186.72 |
| Sales Surprise: | 0.41% | EPS Surprise: | 7.22% | Sales Q/Q: | -1.82% | Earnings: | Apr 30 AMC | Avg Volume: | 1.29M | Price: | 188.29 |
| SMA20: | 4.39% | SMA50: | 10.59% | SMA200: | -9.85% | Undervalued: 23.34% | Volume: | 703,045 | Change: | 0.84% | |
Graham Classic formula value: 140.95
(P/E=8 * 1g) Min value: 89.0
(current P/E * 2g) Max value: 268.18
Average value: 166.04
About Align Technology, Inc
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad's CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.